Search

Displaying results 4471 - 4480 of 7452 in total
  1. Drug

    Aminaphthone

    go.drugbank.com/drugs/DB13039
    Investigational

    Aminaftone has been investigated for the treatment of Cockett Syndrome, May-Thurner Syndrome, and Iliac Vein Obstruction.

  2. Drug

    XEN-D0501

    go.drugbank.com/drugs/DB18673
    Investigational

    XEN-D0501 is a tetrahydronaphthyl urea-based selective TRPV1 antagonist being investigated for the treatment of erythromelalgia.

  3. Drug

    Daphnetin

    go.drugbank.com/drugs/DB18965
    Investigational

    Daphnetin is under investigation in clinical trial NCT06329167 (Daphnetin Capsules for Lower Limb Lymphoedema Following Gynaecological Surgery).

  4. Drug

    Radavirsen

    go.drugbank.com/drugs/DB15332
    Investigational

    Radavirsen is under investigation in clinical trial NCT01375985 (Safety Study of Single Administration Intravenous Treatment for Influenza).

  5. Drug

    Norleucine

    go.drugbank.com/drugs/DB15458
    Investigational

    Norleucine is under investigation in clinical trial NCT00081952 (Amino Acid Therapy for Hot Flashes in Postmenopausal Women).

  6. Drug

    Influenza B virus B/Michigan/01/2021 antigen (formaldehyde inactivated)

    go.drugbank.com/drugs/DB16917
    Approved

    In contrast, live vaccines are produced from "wild-type" or disease-causing viruses that have been attenuated, or weakened, through various laboratory techniques. … Inactivated vaccines contain a virus particle that has been grown in media and then subsequently killed, or inactivated, through exposure to heat or chemicals such as formaldehyde.

  7. Drug

    Sulfaperin

    go.drugbank.com/drugs/DB13320
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  8. Drug

    Sulfametomidine

    go.drugbank.com/drugs/DB13485
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  9. Drug

    MB07811

    go.drugbank.com/drugs/DB05192
    Investigational

    The combination of selectivity for the beta form of the receptor, liver targeting and other structural characteristics that limit extra-hepatic activity is designed to provide significant efficacy while

  10. Drug

    Diphemanil

    go.drugbank.com/drugs/DB13720
    ApprovedVet approvedWithdrawn

    Categories: Drugs for Functional Gastrointestinal Disorders